Public limited company · Gent · incorporated on 03/04/1991 · 0,0 ETP
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -25,3 k € | -107.5% | 339,7 k € | +1444.1% | -25,3 k € | -216.1% | 21,8 k € | -45.0% | 39,6 k € | +7.7% | 36,7 k € | +313.1% | -17,2 k € | -188.8% | 19,4 k € | -26.0% | 26,2 k € | +10.0% | 23,9 k € | -55.5% | 53,7 k € | -18.5% | 65,9 k € | +2.2% | 64,4 k € | +53.0% | 42,1 k € | +500.9% | 7,0 k € | -65.4% | 20,3 k € | +0.9% | 20,1 k € | -91.6% | 238,9 k € | +6.1% | 225,2 k € | -83.0% | 1,3 M € | |
| EBITDA | -42,9 k € | -113.4% | 320,8 k € | +716.5% | -52,0 k € | -1489.7% | 3,7 k € | -79.2% | 18,0 k € | -37.1% | 28,6 k € | +205.6% | -27,1 k € | -400.3% | 9,0 k € | -44.2% | 16,2 k € | +16.7% | 13,8 k € | -68.3% | 43,7 k € | -18.9% | 53,8 k € | -3.1% | 55,6 k € | +69.5% | 32,8 k € | +1727.7% | -2,0 k € | -117.8% | 11,3 k € | +1.6% | 11,1 k € | -95.2% | 230,9 k € | +6.1% | 217,6 k € | -83.4% | 1,3 M € | |
| Operating profit | -57,4 k € | -118.9% | 303,3 k € | +494.7% | -76,8 k € | -186.3% | -26,8 k € | -112.7% | -12,6 k € | -433.7% | -2,4 k € | +95.9% | -58,0 k € | -58.0% | -36,7 k € | -54.4% | -23,8 k € | +15.7% | -28,2 k € | -3299.1% | -829,9 € | -106.3% | 13,1 k € | -53.1% | 28,0 k € | +703.4% | -4,6 k € | +88.8% | -41,4 k € | -44.5% | -28,6 k € | -12.4% | -25,5 k € | -113.8% | 185,0 k € | +11.7% | 165,7 k € | -86.8% | 1,3 M € | |
| Profit/loss | 159,8 k € | -76.4% | 676,6 k € | +70.0% | 398,0 k € | +14.8% | 346,8 k € | +33.8% | 259,2 k € | -11.2% | 291,9 k € | -19.7% | 363,4 k € | -57.6% | 856,3 k € | +79.2% | 477,9 k € | -46.8% | 898,4 k € | -32.2% | 1,3 M € | +34.5% | 985,7 k € | -44.9% | 1,8 M € | -8.9% | 2,0 M € | +8.0% | 1,8 M € | +15.6% | 1,6 M € | -5.6% | 1,7 M € | -10.6% | 1,9 M € | +6.5% | 1,8 M € | -92.7% | 24,1 M € | |
| Equity | 52,7 M € | +0.3% | 52,6 M € | +1.3% | 51,9 M € | +0.8% | 51,5 M € | +0.7% | 51,1 M € | +0.5% | 50,9 M € | +0.6% | 50,6 M € | +0.7% | 50,2 M € | +1.7% | 49,4 M € | +1.0% | 48,9 M € | +1.9% | 48,0 M € | +2.8% | 46,7 M € | +2.2% | 45,7 M € | +3.1% | 44,3 M € | +4.6% | 42,3 M € | +4.5% | 40,5 M € | +4.0% | 38,9 M € | +4.5% | 37,3 M € | +4.3% | 35,7 M € | +4.2% | 34,3 M € | |
| Total assets | 53,4 M € | -0.3% | 53,6 M € | +1.4% | 52,9 M € | +1.9% | 51,9 M € | -1.9% | 52,9 M € | -0.2% | 53,0 M € | +0.6% | 52,7 M € | +0.8% | 52,3 M € | +2.6% | 51,0 M € | +0.6% | 50,6 M € | +1.7% | 49,8 M € | +2.5% | 48,5 M € | +0.9% | 48,1 M € | +0.5% | 47,9 M € | +4.0% | 46,0 M € | +4.5% | 44,0 M € | +3.9% | 42,4 M € | +4.6% | 40,5 M € | +3.6% | 39,1 M € | -21.7% | 50,0 M € | |
| Cash | 292,5 k € | -86.5% | 2,2 M € | -62.0% | 5,7 M € | +18.2% | 4,8 M € | -31.7% | 7,0 M € | -24.1% | 9,3 M € | +23.6% | 7,5 M € | -0.4% | 7,5 M € | +20.4% | 6,3 M € | -7.7% | 6,8 M € | -10.2% | 7,6 M € | +39.7% | 5,4 M € | +23.9% | 4,4 M € | -10.0% | 4,9 M € | +86.1% | 2,6 M € | +68.4% | 1,5 M € | +278.7% | 408,8 k € | -92.9% | 5,8 M € | +60.8% | 3,6 M € | +35.3% | 2,6 M € | |
| Debts | 711,4 k € | -31.5% | 1,0 M € | +4.4% | 994,5 k € | +157.3% | 386,5 k € | -77.5% | 1,7 M € | -18.5% | 2,1 M € | +1.4% | 2,1 M € | +1.6% | 2,0 M € | +28.7% | 1,6 M € | -9.3% | 1,8 M € | -2.2% | 1,8 M € | -4.8% | 1,9 M € | -22.1% | 2,4 M € | -32.4% | 3,6 M € | -3.3% | 3,7 M € | +4.6% | 3,5 M € | +2.2% | 3,5 M € | +5.6% | 3,3 M € | -3.3% | 3,4 M € | -78.4% | 15,7 M € | |
| Staff | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||
Source: Belgian Official Gazette
Public limited company profitable and well capitalised. Cash position declining (-86.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MADO is a Public limited company incorporated in 1991. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.